- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prospects for combined use of oncolytic viruses and CAR T-cells ; volume:5 ; number:1 ; day:21 ; month:11 ; year:2017 ; pages:1-27 ; date:12.2017
Journal for ImmunoTherapy of Cancer ; 5, Heft 1 (21.11.2017), 1-27, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Ajina, Adam
- Beteiligte Personen und Organisationen
-
Maher, John
SpringerLink (Online service)
- DOI
-
10.1186/s40425-017-0294-6
- URN
-
urn:nbn:de:1111-201801059021
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ajina, Adam
- Maher, John
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
Oncolytic virus immunotherapy: future prospects for oncology
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Pharmacological control of CAR T-cells by dasatinib
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
Oncolytic virus immunotherapy: future prospects for oncology
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Pharmacological control of CAR T-cells by dasatinib
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
Oncolytic virus immunotherapy: future prospects for oncology
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond